What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Hismanal
96%DGNews: New Hismanal Labelling Warns Of Drug Interaction Complications
84%DGNews: Sporanox Available In US For Life-Threatening Fungal Infections
84%DGNews: Posicor Gets FDA Approval For High Blood Pressure, Angina
81%DGNews: FDA Approves Sporanox For Fungal Infections
81%DGNews: Sustiva (Efavirenz) Instead Of Protease Inhibitor Maintains Antiretroviral Control
80%DGNews: Serzone Is Associated with Greater Improvement Of Sleep Quality -- Study
79%DGNews: AIDS2000: Potent Results Seen With Sustiva (Efavirenz) And ABT- 378/Ritonavir Combination
77%DGNews: SPORANOX Capsules Cleared for New 'Pulse' Dosing
76%DGNews: R-albuterol Asthma Trial for Children Under the Age of 12
75%DGNews: SPORANOX Sets Records For Treatment of Toenail Fungus
74%DGNews: ICAAC: Crixivan (Indinavir)/Ritonavir Combo Markedly Suppresses Viral Levels In HIV
73%DGNews: FDA Approves Once-Daily Kaletra-Based (Lopinavir/Ritonavir) Treatment Regimen
73%DGNews: ICAAC: Sustiva (Efavirenz) Effective, Well Tolerated In Combination Therapy For HIV Positive Patients
73%DGNews: Novel Chronic Depression Treatment Study Evaluates Serzone
73%DGNews: Sporanox Now Indicated to Treat Fungal Nail Disease
72%DGNews: Sustiva First Anti-HIV Drug Approved By FDA Based On Long-Term Efficacy
72%DGNews: CROI: Crixivan/ZDV/3TC Combo Suppresses Viral Loads In Early HIV
71%DGNews: FDA Approves Reyataz(R) (Atazanavir Sulfate) 300 mg Single Capsule Formulation in Combination Therapy for Adults With HIV-1 Infection
71%DGNews: SABCS: Emend (Aprepitant) Significantly Improved Control of Chemotherapy-Induced Nausea and Vomiting in both Women and Men
71%DGNews: Data From Cohort Study Showed Better Virologic Response in Regimens Containing SUSTIVA(R) Compared to Viramune(R)-Containing Regimens in HIV Treatment-Naive Patients
71%DGNews: IAS: Sustiva (Efavirenz) Shows Advantage Over Viramune (Nevirapine)/Protease Inhibitors in Human Immunodeficiency Virus
71%DGNews: BHIVA: Sustiva (Efavirenz) Demonstrates Advantage Over Viramune (Nevirapine) and Protease Inhibitors in HIV Positive Patients
71%DGNews: Sustiva (Efavirenz) Prescribed More Often Than Crixivan (Indinavir) For HIV/AIDS
70%DGNews: Abbott Receives FDA Approval for New Kaletra (Lopinavir/Ritonavir) Tablet Formulation for HIV Patients
70%DGNews: ICAAC: Blood Levels of Crixivan Boosted By Ritonavir
69%DGNews: FDA Approves Emend (Aprepitant), Merck's Antiemetic Therapy, for the Prevention of Postoperative Nausea and Vomiting
69%DGNews: ICAAC: Selective Serotonin Reuptake Inhibitors Do Not Affect Anti-HIV Sustiva (Efavirenz)
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.